Audeara’s Strategic Expansion and Partnerships: Transforming Hearing Health

3–4 minutes

To read

Chris Titley recently interviewed James Fielding, the founder and managing director of Audeara, on the Sub11 podcast, shedding light on Audeara’s advancements in hearing health technology, strategic global partnerships, and recent announcements, particularly involving Apple and innovations in the Asian market.

Audeara, founded in 2015, has steadily evolved from a Kickstarter-backed headphone project to a global player in hearing technology, offering both direct consumer products and B2B solutions to major audiology providers worldwide.

James Fielding provided insights into Audeara’s journey from its initial focus on consumer hardware to a strategic shift toward B2B partnerships. “The real shift for us,” Fielding explains, “came when we recognised the potential in audiology clinics. Working directly with clinics not only increased awareness but also enabled us to skip the traditional hurdles of building awareness in the consumer market.”

Today, Audeara holds supply agreements with major audiology providers, including a global partnership with Amplifon, the world’s largest audiology clinic network. This transition has allowed the company to expand globally and secure supply agreements that now include Europe, Asia, and North America.

A pivotal moment for Audeara was the launch of the
AUA Tech business unit, which integrates their personalisation technology into third-party brands. The collaboration with Zildjian, a 400-year-old musical instrument company, exemplifies this strategy. “Zildjian wanted a continuation of their legacy, and they chose us to bring our personalisation technology into their new product line,” Fielding stated. This partnership generated a $2.1 million purchase order, reinforcing Audeara’s commitment to scaling through technology licensing while delivering superior auditory experiences for end users.

An announcement from Apple added a unique dynamic to Audeara’s trajectory. On the same day Audeara launched its hearing aid-compatible earbuds in China, Apple unveiled hearing enhancement features in their AirPod Pro 2, targeting the U.S. market. Fielding addressed the competitive landscape optimistically, saying, “The presence of Apple creates a buzz around hearing health. We’re proud that our product can stand alongside theirs, serving users who seek hearing enhancement without the stigma often associated with traditional hearing aids.”

In Asia, Audeara’s partnership with Eastech signifies their intent to penetrate the massive Chinese medical device market. “This partnership de-risks our entry into China by leveraging Eastech’s manufacturing capabilities and their knowledge of the market. Our role is to provide the technology that underpins these devices,” Fielding said. Eastech’s well-established brand presence in China allows Audeara to focus on its core technology while reaching millions of potential users.

Reflecting on the last quarter, Fielding was clear that Audeara’s trajectory involves “growth at appropriate cost,” balancing ambitious expansion with capital efficiency. He credited the company’s board and team for navigating a challenging market environment, which included a focus on profitability and rigorous cost management. “This strategy has positioned us to pursue large-scale deals, especially in high-growth markets,” he added.

Audeara’s future is marked by a commitment to creating a sustainable business model through innovation, strategic partnerships, and global expansion. Fielding emphasized the importance of aligning with industry giants, “We’re proud to be working with the ‘gorillas’ in audiology, bringing our world-class tech to global markets.”

Listen to the podcast here :

ASX Code: AUA

This content is factual information only, does not contain financial product advice and has not been prepared in consideration of your personal circumstances or needs. Views shared by individuals are their own personal views and not the views of Sub11. We are not licenced to provide financial product advice and cannot make investment recommendations to you. Investments carry risk. Please consider seeking professional financial advice, and read the relevant disclosure documents, before making any decisions to invest in financial products.

Audeara and Sub11 are in a commercial relationship which includes production of media mediums such as video, audio and social media. All questioning is created by Sub11, not Audeara.

Leave a Reply

Discover more from Sub11 - Investor Engagement

Subscribe now to keep reading and get access to the full archive.

Continue reading